ÄϹ¬NG28¼¯ÍÅ

nyba2
ѧУҪÎÅ
Ê×Ò³ > ѧУҪÎÅ > ÕýÎÄ
ѧУҪÎÅ
ѧУҪÎÅ

ÄϹ¬NG28¼¯ÍÅÐÜÐ˶«½ÌÊÚÔÚMolecular Therapy-Nucleic Acids½ÒÏþÂÛÎÄÕ¹ÏÖеÄѪ¹ÜÄÚÆ¤Ï¸°ûÐàÂõµ÷¿Ø»úÖÆ

ȪԴ£º ʱ¼ä£º2021-09-28µã»÷£º

¿ËÈÕ£¬ÄϹ¬NG28¼¯ÍÅÐàÂõÑо¿ËùÐÜÐ˶«½ÌÊÚÍŶÓÒÔÄϹ¬NG28¼¯ÍÅΪΨһͨѶµ¥Î»ÔÚ¹ú¼Ê×ÅÃûѧÊõÆÚ¿¯Molecular Therapy-Nucleic Acids(ÖпÆÔº¶þÇø£¬IF=8.889)ÉϽÒÏþÁË×îÐÂÑо¿Ð§¹û£¢circGNAQ, a circular RNA enriched in vascular endothelium, inhibits endothelial cell senescence and atherosclerosis progression£¢¡£¡ £¡£¡£¡ £¡£¡£¸ÃÑо¿Ê×´ÎÕ¹ÏÖÁË»·×´RNA circGNAQͨ¹ýcircGNAQ/miR-146a-5p/PLK2ÐźÅͨ·µ÷¿ØÑª¹ÜÄÚÆ¤Ï¸°ûÐàÂõ£¬ÑÓ»º¶¯ÂöÖàÑùÓ²»¯µÄ±¬·¢¡£¡ £¡£¡£¡ £¡£¡£

0F48386B9D2EE211F030C55B82C_5EAEA275_1BA35

¶¯ÂöÖàÑùÓ²»¯¡¢¡¢¹ÚÐIJ¡µÈÐÄѪ¹Ü¼²²¡ÒѳÉΪÍþвÎÒ¹ú¹«ÖÚ¿µ½¡µÄÖ÷Òª¼²²¡¡£¡ £¡£¡£¡ £¡£¡£Ñª¹ÜË¥×ÜÊÇÕâЩÐÄѪ¹Ü¼²²¡µÄÖ÷ҪΣÏÕÒòËØ¡£¡ £¡£¡£¡ £¡£¡£¶øÑª¹ÜÄÚÆ¤Ï¸°ûË¥×ÜÊÇѪ¹ÜÐàÂõµÄ»ù´¡£¬ÑÓ»ºÑª¹ÜÄÚÆ¤Ï¸°ûÐàÂõ¿ÉÓÐÓÃÔ¤·ÀºÍïÔÌ­ÕâЩÐÄѪ¹Ü¼²²¡µÄ±¬·¢¡£¡ £¡£¡£¡ £¡£¡£»£»£»·×´RNA£¨circular RNA, circRNA£©ÊÇÒ»Àà¾ßÓбպϻ·×´½á¹¹µÄÄÚÔ´ÐÔRNA·Ö×Ó£¬Ö÷ÒªÓÉǰÌåRNA£¨pre-mRNA£©Í¨¹ý¿É±ä¼ôÇмӹ¤±¬·¢¡£¡ £¡£¡£¡ £¡£¡£ËüÆÕ±é±£´æÓÚÖÖÖÖϸ°ûÖУ¬¾ßÓбí´ïƷò¸ß¡¢¡¢½á¹¹Îȹ̺Í×éÖ¯ÌØÒìÐÔ±í´ïµÈÌØÕ÷¡£¡ £¡£¡£¡ £¡£¡£±¾Ñо¿Ê¹ÓøßͨÁ¿²âÐòÊÖÒÕɸѡ³öÔÚѪ¹ÜÄÚÆ¤Ï¸°ûÐàÂõÀú³ÌÖвî±ð±í´ïµÄcircRNAs£¬Í¨¹ýÌåÍâʵÑé֤ʵÆäÖÐcircGNAQ¿ÉÒÔÎü¸½miR-146a-5p£¬×è¶ÏmiR-146a-5p¶ÔÆäÏÂÓΰлùÒòPLK2µÄÒÖÖÆ×÷Ó㬽ø¶øÑÓ»ºÑª¹ÜÄÚÆ¤Ï¸°ûµÄÐàÂõ¡£¡ £¡£¡£¡ £¡£¡£Í¬Ê±£¬ÌåÄÚʵÑé·¢Ã÷circGNAQÔÚѪ¹ÜÄÚÆ¤ÖÐÌØÒìÐԸ߱í´ï£¬ÇÒÆä±í´ïËæ×Ŷ¯ÂöÖàÑùÓ²»¯Àú³Ì³ÖÐøÏµ÷£»£»£»ÔÚASÄ£×ÓСÊóµÄѪ¹ÜÄÚÆ¤Ï¸°ûÖÐÌØÒì¹ý±í´ïcircGNAQ¿ÉÒÔÏÔ×ÅÑÓ»ºÑª¹ÜÐàÂõºÍïÔÌ­¶¯ÂöÖàÑùÓ²»¯µÄ±¬·¢¡£¡ £¡£¡£¡ £¡£¡£±¾Ñо¿Õ¹ÏÖÁËcircGNAQµ÷¿ØÑª¹ÜÄÚÆ¤Ï¸°ûÐàÂõµÄ×÷ÓûúÖÆ£¬ÎªÑÓ»ºÑª¹ÜÐàÂõ¡¢¡¢Ô¤·ÀºÍÖÎÁƶ¯ÂöÖàÑùÓ²»¯ÌṩеÄ˼Ð÷ºÍÖÎÁÆÕ½ÂÔ¡£¡ £¡£¡£¡ £¡£¡£

21CC0827C2331302EC3BB4C68E8_4C6B190B_1BC00

¸ÃÑо¿»ñµÃ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¡¢¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ð¡¢¡¢¶«Ý¸¿Æ¼¼Á¢ÒìÁìÎäÊ¿²Å¼°ÄϹ¬NG28¼¯ÍÅѧ¿Æ½¨ÉèÏîÄ¿µÄ×ÊÖú¡£¡ £¡£¡£¡ £¡£¡£Ñо¿ÉúÎ×ΰÅô¡¢¡¢ÖÜÃÈæÂ¡¢¡¢Áõ¶«ÁÁºÍãÉÑ©ÊǸÃÂÛÎĵÄÅäºÏµÚÒ»×÷Õߣ¬Í¨Ñ¶×÷ÕßΪÐÜÐ˶«½ÌÊÚ¡£¡ £¡£¡£¡ £¡£¡£

50C62AB8030B354102D5485B931_A0E2818C_18EBE

£¨ÎÄ¡¢¡¢Í¼/ÉÛÍ© ±à/ÖÜÔ² Éó/·ë½õɽ£©

¡¾¹Ø±Õ¡¿

×îÐÂÐÂÎÅ
¡¾ÍøÕ¾µØÍ¼¡¿